Overcoming neurite‐inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Acute trauma to the central nervous system (CNS) can result in permanent damage and loss of function related to the poor regeneration of injured axons. Injured axons encounter several barriers to regeneration, such as the glial scar at the injury site. The glial scar contains extracellular matrix (ECM) macromolecules deposited by reactive astrocytes in response to injury. The scar ECM is rich in chondroitin sulfate proteoglycans (CSPGs), macromolecules that inhibit axonal growth. CSPGs consist of a core protein with attachment sites for glycosaminoglycan (GAG) chains. An extensive literature demonstrates that enzymatic removal of the GAG chains by chondroitinase ABC permits some axonal regrowth; however, the remaining intact core proteins also possess inhibitory domains. Because metalloproteinases can degrade core proteins of CSPGs, we have evaluated five matrix metalloproteinases (MMPs) and a related protease—a disintegrin and metalloproteinase with thrombospondin motifs‐4 (ADAMTS‐4)—for their capacity to overcome CSPG inhibition of neuritic growth in culture. The metalloproteinases were selected for their known expression after CNS injuries. Of the MMPs, MMP‐3, ‐7 and ‐8 reduced or abolished inhibition of neurite outgrowth on a purified CSPG substrate and on an astrocyte‐derived ECM. ADAMTS‐4 also attenuated CSPG inhibition of neurites and had the additional benefits of neither degrading laminin nor causing neurotoxicity. The efficacy of ADAMTS‐4 matched that of blocking the EGFR signaling previously reported to mediate CSPG inhibition. These findings highlight ADAMTS‐4 as a superior protease for overcoming CSPG inhibition of axonal regeneration in the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959 · cited 2×
“MMPs collectively degrade all ECM proteins including CSPGs (McCawley and Matrisian, 2001; Sternlicht and Werb, 2001).”
BackgroundMolecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 1×
“…because of their production of axon-inhibitory CSPGs, we note that there are many useful properties of reactive astrocytes, including the restoration of structural and physiological integrity at the lesion site, and the neutralization of neurotoxic factors (Sofroniew, 2009; Williams et al., 2007).”
BackgroundChondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 4×
“972 VC 2013 Wiley Periodicals, Inc. chondroitin sulfate GAG chains using chondroitinase ABC (ChABC), a glycanase enzyme isolated from Proteus vulgaris bacteria, facilitates axonal regrowth and improves functional recovery (Bradbury and Carter, 2011; Bradbury et al., 2002).”
BackgroundInfluentialMatrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Fitch, M. T., & Silver, J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.014 · Cited by 1,007 · cited 2×
“For example, in spinal cord injury, the ECM surrounding sites of axonal loss has an abundance of molecules that restrict axonal regeneration; the most prominent of these inhibitory glial scar constituents are the CSPGs (Fitch and Silver, 2008; Laabs et al., 2005; Sandvig et al., 2004; Yu et al., 2012).”
BackgroundDavies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 2×
“…in part because the astrocyte-deposited extracellular matrix (ECM) includes an array of proteogly- cans, most notably the chondroitin sulfate proteoglycans (CSPGs) (Ard et al., 1993; Davies et al., 1999; Jones et al., 2003; Sandvig et al., 2004; Silver and Miller, 2004; Chan et al., 2007).”
BackgroundMetalloproteinases: Mediators of Pathology and Regeneration in the CNS
Yong, V. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1807 · Cited by 582 · cited 2×
“Several MMPs are locally elevated after CNS injuries where their diverse roles include neurotoxicity and repair (Cunningham et al., 2005; Yong et al., 1998; Yong, 2005; Zhao et al., 2006).”
BackgroundSelf-citationZuo, J., Ferguson, T. A., Hernandez, Y. J., Stetler-Stevenson, W. G., & Muir, D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05203.1998 · Cited by 270
Brain derived versican V2 is a potent inhibitor of axonal growth
Schmalfeldt, M., Bandtlow, C. E., Dours-Zimmermann, M. T., Winterhalter, K. H., & Zimmermann, D. R. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.5.807 · Cited by 197
Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., & Noble-Haeusslein, L. J. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0038-0 · Cited by 163 · cited 1×
“In traumatic spinal cord injury, MMP-9 contributes to lesion development while MMP-2 may help in reparative processes (Hsu et al., 2006; Noble et al., 2002; Zhang et al., 2011).”
Background
Cited by
The Biology of Regeneration Failure and Success After Spinal Cord Injury
Tran, A. P., Warren, P. M., & Silver, J. (2018) · Physiological Reviews · doi:10.1152/physrev.00017.2017 · Cited by 884
Crosstalk between glia, extracellular matrix and neurons
Song, I., & Dityatev, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.003 · Cited by 262
Dong, Y., D’Mello, C., Pinsky, W., Lozinski, B. M., Kaushik, D. K., Ghorbani, S., Moezzi, D., Brown, D., Melo, F. C., Zandee, S., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00801-z · Cited by 181
Self-citationMicroglia as hackers of the matrix: sculpting synapses and the extracellular space
Crapser, J. D., Arreola, M. A., Tsourmas, K. I., & Green, K. N. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00751-3 · Cited by 178
ADAMTS proteoglycanases in the physiological and pathological central nervous system.
Lemarchant, S., Pruvost, M., Montaner, J., Emery, E., Vivien, D., Kanninen, K., & Koistinaho, J. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-133 · Cited by 96
“While the expression and associated beneficial or deleterious effects of matrix metalloproteinases (MMPs) have been extensively reported in several CNS diseases, recent publications strongly suggest that the ADAMTS proteoglycanases may also be important in ECM proteolysis in CNS injuries.”
Background
Metadata
- Authors
- Cua, R. C., Lau, L. W., Keough, M. B., Midha, R., Apte, S. S., & Yong, V. W.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2013-03-28
- Volume
- 61
- Issue
- 6
- Pages
- 972-984
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1567473013
- Cited by
- 87
- References
- 13
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overcoming neurite‐inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. https://app.cochat.ai/papers/10.1002/glia.22489
- The paper
- Cua, R. C., Lau, L. W., Keough, M. B., Midha, R., Apte, S. S., & Yong, V. W. (2013). Overcoming neurite‐inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. Glia. https://doi.org/10.1002/glia.22489
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.